|

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

RECRUITINGN/ASponsored by Tel-Aviv Sourasky Medical Center
Actively Recruiting
PhaseN/A
SponsorTel-Aviv Sourasky Medical Center
Started2025-03-01
Est. completion2027-03-01
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted

Summary

This is a research study involving patients hospitalized for COPD flare-ups. Patients will be randomly assigned to two groups: one group will only see a pulmonologist (lung doctor), and the other group will also be seen by a cardiologist (heart doctor) during their hospital stay. Both groups will fill out a questionnaire, and the pulmonologist will review their lung disease, adjust their treatment, and recommend follow-up care. The cardiologist will also assess the second group for heart diseases (like high cholesterol, diabetes, heart disease, high blood pressure, or heart failure) and start or adjust heart treatment if needed. Both groups will be followed up by phone 1, 3, 6 and 12 months later to check for changes in treatment, new heart problems, COPD flare-ups, or death.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Documented COPD (based on lung function tests, symptoms and relevant treatment).
* Aged 18-75 years.
* Mentally competent to understand and follow medical recommendations.

Exclusion Criteria:

* Under 18 years of age.
* Unable to provide consent.
* Unstable concurrent disease.

Conditions3

COPDCOPD - Chronic Obstructive Pulmonary DiseaseCardiovascular Diseases

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.